Abbott Hit With Shareholder Suit Over Depakote Marketing
A union pension fund shareholder sued Abbott Laboratories Inc. and its directors in Illinois federal court Tuesday, alleging they let anti-seizure drug Depakote be illegally marketed for off-label use, resulting in...To view the full article, register now.
Already a subscriber? Click here to view full article